HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Continue to convene the PAWG to provide advice to innovators prior to submission of PSPs/PIPs, communicate technical opinions to SRAs in a timely manner, and provide dosing and ratio recommendations to generics for development of new FDCs.
World Health Organisation (WHO)
Sub-Actions & Milestones
Continue to convene the PAWG to provide advice to innovators prior to submission of PSPs/PIPs and communicate technical opinions to SRAs in a timely manner.
WHO
-
Sub-action on-going
PAWG will communicate dosing and ratio for DTG/ABC/3TC and DTG/XTC/TAF as soon as individual dosing are confirmed
-
-
-
PAWG to review PIPs to provide feedback on alignment with PADO, prioritization and timelines
WHO
WHO/PAWG sent a letter to EMA including considerations for implementation of existing PIPs. Letter includes feedback from PAWG on PIPs for EMA. The messages of the letter will be communicated to relevant companies on dedicated calls with PAWG members to facilitate dialogue. PAWG members will remain available to discuss specific products with relevant innovators.
These considérations were also shared with members of the FDA technical team.
Milestone on-going
PSPs not publicly available for review
Provide dosing and ratio recommendations to generics for development of new FDCs.
WHO
-
-
-
-
-
-
-
-
-
-
Updates
Notes
Responsible